ASMB
ASMB
NASDAQ · Biotechnology

Assembly Biosciences Inc

$26.54
+0.10 (+0.36%)
As of Aug 8, 1:56 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -58.8% upside
Low Target $9.01
Average Target $10.92
High Target $17.95
Current Price $26.54
Current
$26.54
Target
$10.92
$9.01 $10.92 avg $17.95
Scenario Analysis
Bear Case
$9.01
-66.0%
Low target
Base Case
$10.92
-58.8%
Avg target
Bull Case
$17.95
+-32.4%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$39.71
-33.2% from high
52-Week Low
$18.50
+43.4% from low
Target vs 52W High
$10.92
-72.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%